Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 16.6.2023Novo Nordisk A/S (NOO)1676DNorditropin NordiFlex 5 mg/1,5 ml (sol ira 1x1,5 ml (náplň skl. v napl.inj.pere))16.6.2023R
 16.6.2023Roche Registration GmbH (HLR-DE)14548NeoRecormon 3 000 IU injekčný roztok naplnený v injekčnej striekačke (sol inj 6x0,3 ml/3 000 IU (napl.inj.striek.skl.))16.6.2023Z
 16.6.2023Roche Registration GmbH (HLR-DE)41488NeoRecormon 6 000 IU injekčný roztok naplnený v injekčnej striekačke (sol inj 6x0,3 ml/6 000 IU (striek.inj.napl.skl.))16.6.2023Z
 16.6.2023Zentiva k.s. (ZNT-3)4696DXanirva 20 mg filmom obalené tablety (tbl flm 28x20 mg (blis.PVC/Al))20.6.2023O
 16.6.2023Zentiva k.s. (ZNT-3)4699DXanirva 20 mg filmom obalené tablety (tbl flm 98x20 mg (blis.PVC/Al))20.6.2023O
 16.6.2023Zentiva, k.s. (ZNT-1)14082MYCOMAX 150 (cps dur 1x150 mg (blis.PVC/PE/PVDC/Al))26.6.2023O
 16.6.2023Zentiva, k.s. (ZNT-1)3049BTorvacard Novum 20 mg (tbl flm 30x20 mg (blis.OPA/Al/PVC/Al))20.6.2023O
 16.6.2023Zentiva, k.s. (ZNT-1)81771Valzap 80 mg (tbl flm 28x80 mg (blis.PVC/PE/PVDC/Al))22.6.2023O
 16.6.2023Zentiva k.s. (ZNT-3)4676DXanirva 2,5 mg filmom obalené tablety (tbl flm 56x2,5 mg (blis.PVC/Al))23.6.2023U
 16.6.2023McNeil Healthcare (Ireland) Limited (MCP-2)6796COLYNTH PLUS 0,5 mg/50 mg/ml nosová roztoková aerodisperzia (aer nao 1x10 ml (fľ.HDPE biela))9.6.2023R
 16.6.2023McNeil Healthcare (Ireland) Limited (MCP-3)6797COLYNTH PLUS 1 mg/50 mg/ml nosový roztokový sprej (aer nao 1x10 ml (fľ.HDPE biela))9.6.2023R
 16.6.2023BELUPO, s.r.o. (BLU-SK)4000CSPIRABEL 5 mg orodispergovateľné tablety (tbl oro 30(3x10)x5 mg (blis.Al/Al))16.6.2023O
 15.6.2023KRKA, d.d., Novo mesto (KRK-2)80756Vizarsin 100 mg filmom obalené tablety (tbl flm 8x1x100 mg (blis.PVC/Al))19.6.2023O
 14.6.2023TEVA Pharmaceuticals Slovakia s.r.o. (TEV-SK)3383AEplerenone Teva 50 mg (tbl flm 90x1x50 mg (blis.PVC/PVDC/Al perf.))23.6.2023O
 14.6.2023TEVA Pharmaceuticals Slovakia s.r.o. (TEV-SK)3401AEplerenone Teva 25 mg (tbl flm 90x1x25 mg (blis.PVC/PVDC/Al perf.))14.6.2023O

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)